市场调查报告书
商品编码
1492501
角膜手术设备市场:按设备类型、应用和最终用户划分 - 2024-2030 年全球预测Corneal Surgery Device Market by Device Type (Corneal Topography Systems, Excimer Lasers, Femtosecond Lasers), Application (Corneal Transplantation, Keratoplasty, Refractive Error Correction), End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
角膜手术设备市场规模预计2023年为74.8亿美元,2024年达到80.3亿美元,预计2030年将达到124.4亿美元,复合年增长率为7.52%。
角膜手术装置是眼科外科医生用来对角膜(眼球的透明前表面)进行手术的医疗器械。这些设备可用于重塑角膜以改善视力,如在LASIK手术中,修復损伤,或在严重损伤或疾病的情况下用供体组织替换部分或全部角膜。角膜手术设备使用的技术各不相同,包括用于精密切割和再形成的雷射系统,以及用于手动操作和角膜组织移植的仪器。这些设备在改善视力和治疗与角膜相关的视力问题方面发挥着重要作用。由于视力障碍和角膜疾病的增加以及老年人口的增加,角膜疾病的盛行率普遍较高,刺激了角膜手术的需求。此外,对医疗保健基础设施的投资正在增加,特别是在发展中国家,从而提高了手术护理的可近性和品质。然而,先进角膜手术设备的高价格可能会限制市场成长,特别是在低收入国家。有关医疗设备核准的严格法规可能会延迟产品上市并影响市场成长。此外,手术技术和设备的不断创新使手术更安全、更有效,从而提高了成功率。人工智慧和机器学习的整合有可能改善诊断系统和手术准确性并改善治疗结果。
主要市场统计 | |
---|---|
基准年[2023] | 74.8亿美元 |
预测年份 [2024] | 80.3亿美元 |
预测年份 [2030] | 124.4亿美元 |
复合年增长率(%) | 7.52% |
区域洞察
在美洲,由于糖尿病和人口老化等因素,角膜疾病的盛行率很高,增加了对角膜手术设备的需求。美国市场的特点是医疗保健支出高和先进医疗技术的普及。研究和开发活动很活跃,并得到政府和私人资金的支持。值得注意的是对雷射和混合手术设备等新技术的大量投资,旨在提高准确性并缩短恢復时间。在广泛的医疗政策和多个眼科诊所的支持下,欧盟 (EU) 越来越多地引进先进的角膜手术设备。欧盟的研究得到了欧洲医疗机构和私人组织的慷慨资助,重点是提高手术技术和病人安全。欧盟促进医疗设备高标准的法规鼓励对创新技术进行严格的测试和适应。在中东,由于医疗保健投资的增加和训练有素的眼科医生数量的增加,对角膜手术设备的需求正在增长。目前的倡议包括建立一个专门的眼科保健中心,旨在成为区域眼科保健中心。亚太地区的医疗保健产业快速发展,先进医疗设备(包括角膜手术设备)的采用不断增加。政府在改善医疗基础设施和促进医疗技术自给自足方面的努力引人注目。重点是设备的本地生产,以降低成本并改善在全国范围内的分销。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在角膜手术设备市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对角膜手术设备市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该领域竞争性质的宝贵见解,包括累积研究期、片段化优势和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在角膜手术设备市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[181 Pages Report] The Corneal Surgery Device Market size was estimated at USD 7.48 billion in 2023 and expected to reach USD 8.03 billion in 2024, at a CAGR 7.52% to reach USD 12.44 billion by 2030.
A corneal surgery device is a medical tool used by eye surgeons to perform procedures on the cornea, which is the clear front surface of the eye. These devices are designed to treat various conditions of the cornea, including reshaping it for better vision, such as in LASIK surgery, repairing damage, and replacing part or all of the cornea with donor tissue in cases of severe injury and disease. The technology used in corneal surgery devices can vary, including laser systems for precision cutting and reshaping and instruments for manual manipulation and transplantation of corneal tissue. These devices play a crucial role in improving sight and treating vision problems related to the cornea. Rising cases of visual impairments and corneal diseases coupled with growing populations of older age groups typically have a higher incidence of corneal conditions, fueling the demand for corneal surgeries. Moreover, greater investment in healthcare infrastructure, especially in developing countries, expands the accessibility and quality of surgical care. However, high prices of advanced corneal surgery devices can limit market growth, particularly in lower-income countries. Stringent regulations concerning the approval of medical devices can delay product launches and impact market growth. Furthermore, ongoing innovation in surgical techniques and equipment has made procedures safer and more effective, leading to higher success rates. Integration of AI and machine learning could improve diagnostic systems and surgical precision, enhancing outcomes.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 7.48 billion |
Estimated Year [2024] | USD 8.03 billion |
Forecast Year [2030] | USD 12.44 billion |
CAGR (%) | 7.52% |
Regional Insights
In the American region, there is a high prevalence of corneal disorders, driven by factors such as diabetes and aging populations, increasing the demand for corneal surgery devices. The Americas market is characterized by high healthcare expenditure and widespread access to advanced medical technologies. Research and development activities are robust and supported by both government and private funding. Notable is the significant investment in emerging technologies, such as laser and hybrid surgical devices, aiming to enhance precision and reduce recovery times. The European Union shows a strong adoption of advanced corneal surgery devices, backed by extensive healthcare policies and several specialized eye care facilities. Research in the EU is heavily supported by funding from both European health bodies and private entities, focusing on enhancing surgical techniques and patient safety. EU regulations promoting high standards in medical devices facilitate rigorous testing and adaptation of innovative technologies. In the Middle East, the demand for corneal surgery devices is growing, fueled by increasing healthcare investment and a rising number of trained ophthalmologists. Ongoing initiatives include the establishment of specialized eye care centers aiming to become regional hubs for ophthalmic care. The APAC, with a rapidly growing healthcare sector, is witnessing increased adoption of sophisticated medical devices, including corneal surgery devices. Government initiatives aiming to improve healthcare infrastructure and push for self-sufficiency in medical technologies are notable. The focus is on local manufacturing of devices to reduce costs and improve distribution across the vast country.
Market Insights
The market dynamics represent an ever-changing landscape of the Corneal Surgery Device Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Corneal Surgery Device Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Corneal Surgery Device Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
GOOD Vision Technologies Co., Limited Unveils Corneal Mapping Technology
GOOD Vision Technologies Co., Limited introduced its latest advancement in eye care, the K-Shape Corneal Topographer. This device stands out for its ability to provide precise measurements of the cornea's shape and curvature, which are crucial for assessing eye health and planning surgeries such as corneal transplants and custom contact lens fittings. [Published On: 2024-04-15]
FDA Greenlights Bausch & Lomb's TENEO Excimer Laser for LASIK Procedures Addressing Myopia and Myopic Astigmatism
Bausch & Lomb has secured FDA approval for its new TENEO Excimer Laser Platform, specifically designed for LASIK vision correction surgeries focused on myopia (nearsightedness) and myopic astigmatism. This advanced technology aims to enhance precision and efficiency during the surgical process, potentially improving patient outcomes. The TENEO platform incorporates state-of-the-art features that streamline the operational aspects of LASIK surgery, thus reinforcing Bausch & Lomb's commitment to innovation in ophthalmic treatments. [Published On: 2024-01-08]
Johnson & Johnson Vision Unveils Elita Platform for Myopia Correction at ESCRS Congress
Johnson & Johnson Vision has launched the Elita platform at the European Society of Cataract and Refractive Surgeons (ESCRS) Congress, introducing a novel SILK procedure aimed at treating myopia. This innovative approach utilizes advanced technology to reshape the cornea, offering a potentially safer and more effective alternative to traditional surgical methods. [Published On: 2023-08-30]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Corneal Surgery Device Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Corneal Surgery Device Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accutome, Inc., Alcon Inc., Altomed Ltd., Appasamy Associates, Applesurg Surgical Instruments, Bausch + Lomb, BVI Medical, Corza Medical, Haag-Streit Group, HOYA Corporation, Inka Surgical, Johnson & Johnson Services, Inc., Leica Microsystems, Millennium Surgical Corporation, NIDEK CO.,LTD., Pelion Surgical, RUMEX International Co., Topcon Corporation, and Zeiss Group.
Market Segmentation & Coverage